Evidence map›Paper›PMID 41089794›Full record

ArticleReviews in cardiovascular medicine2025

Evolution of Clinical Features in Right Ventricular Outflow Tract Obstruction: Evidence From an Echocardiographic Database in China.

LiYun Su, DanQing Hu, TingXiang Lan, Xiang Zhang, Shuang Liang, QianYao Lai, JinGuo Li, XuDong Sun, Jun Fang

Abstract read
In one paragraph

Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

LiYun SuDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
DanQing HuDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
TingXiang LanDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
Xiang ZhangDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
Shuang LiangDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
QianYao LaiDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
JinGuo LiDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
XuDong SunDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.
Jun FangDepartment of Cardiology, Fujian Medical University Union Hospital; Fujian Cardiovascular Medicine Center; Fujian Institute of Coronary Artery Disease; Fujian Cardiovascular Research Center; Fujian Medical University Heart Center, 350001 Fuzhou, Fujian, China.ORCID https://orcid.org/0000-0003-4243-0861

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Long-term right ventricular outflow tract dysfunction can lead to right and left heart failure. Nonetheless, current data on the clinical characteristics of the right ventricular outflow tract obstruction (RVOTO) in China remain limited. This study analyzed the evolving trends in the observed proportion, etiology, spectrum, and interventions for RVOTO over the past 18 years from a single-center echocardiographic database. Methods: A total of 10,234 RVOTO cases (17,451 records from 2003 to 2020) were included in the transthoracic echocardiography database in China. The RVOTO cases were divided into eight groups according to the different obstruction sites and disease types. Subsequently, RVOTO was categorized into three types: congenital, iatrogenic, and neither congenital nor iatrogenic. Moreover, congenital RVOTO was further classified into simple and complex congenital RVOTO. Next, we calculated the proportion of RVOTO patients who had received interventions. We analyzed the proportions of different types of RVOTO and the variation tendency. Results: During 2003-2008, 2009-2014, and 2015-2020, the observed proportion of RVOTO cases in the total echocardiographic cases decreased (3.2%, 2.1% and 1.8%, respectively; Conclusions: The clinical characteristics of RVOTO have undergone significant changes in China over the past two decades. After the RVOTO intervention, the increasing number of cases with severe PR or residual peripheral PS and a low possibility of reoperation signifies a future necessity for transcatheter pulmonary intervention.

Indexed as

pulmonary regurgitationpulmonary stenosisright ventricular outflow tract obstructiontranscatheter pulmonary intervention

Identifiers

PMID41089794
PMCPMC12516769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.